Close Menu
Home » Consortium Headed by Enigma Dx Receives $2.3M to Develop TB Assay

Consortium Headed by Enigma Dx Receives $2.3M to Develop TB Assay

Mar 11, 2014
|
staff reporter

NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Edited Oil in Use

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

PGx Philanthropy

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

"Wild West"

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

This Week in Science

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

What's Popular?

In PCR

  1. UBS Initiates Coverage of Agilent, Fluidigm, Qiagen

  2. SpeeDx Signs Distributor Deals in Middle East

  3. Molecular Macrolide Resistance Assay Shows Promise for Point-of-Care Use

    Premium

  4. New IDT Multiplexed Target Amplification Technology Promises High Specificity

    Premium

  5. Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.